Medicare Covers Wegovy®?
Medicare is prohibited from paying for weight-loss treatments. But Wegovy® now has an FDA-approved indication beyond weight loss and can now qualify for payment under Part D. Review of FDA approval, Medicare part D, and the SELECT trial the approval was based on.
NPR reported that although "Medicare is prohibited from paying for weight-loss treatments," because Wegovy® now has an FDA-approved indication beyond weight loss, it can qualify for payment under Part D.
Let's review
- The FDA approval information
- CMS Medicare Part D coverage
- The study that showed a reduction in time to cardiovascular death, non-fatal heart attack, or non-fatal stroke with Wegovy® use.
